Patients are caught in the middle as insurers clamp down on paying for treatments or force prior authorizations for care.
Category: Health Care Costs
The Pandemic Forced My Transgender Wife to Fight Our Insurer Over Hormones
The covid pandemic has caused millions of people, particularly LGBTQ adults, to lose their jobs and enroll in Medicaid or insurance through the Affordable Care Act. Yet these plans often don’t fully cover the basics needed by many transgender Americans, such as injectable estrogen, a hormone therapy commonly used by trans women.
Youthful Advisers Help Shape a Mental Health Program for Their Peers
Officials are enthusiastic about the Allcove initiative, modeled on an Australian program. But it will need to show effectiveness and find funding.
What the Stalemate on Capitol Hill Means for Your Drug Prices
Despite big 2020 campaign promises to deliver lower costs on prescription drugs, Democrats have failed to unite around a legislative plan.
Readers and Tweeters Feel Americans’ Pain
KHN gives readers a chance to comment on a recent batch of stories.
Death in Dallas: One Family’s Experience in the Medicaid Gap
Efforts to give 2.2 million Americans health insurance hang in the balance as Congress debates a massive spending bill. The so-called Medicaid gap is felt most acutely in Texas, where about half of those who stand to gain coverage live.
A Covid Test Costing More Than a Tesla? It Happened in Texas.
A patient from Dallas got a PCR test in a free-standing suburban emergency room. The out-of-network charge: $54,000.
The Part of the ‘Free Britney’ Saga That Could Happen to Anyone
Britney Spears was forced into psychiatric care — and compelled to pay for it. That can happen to any patient who has an episode of serious mental illness, piling financial woes onto their stress and vulnerability.
Alzheimer’s Drug Targets People With Mild Cognitive Impairment. What Does That Mean?
The condition can be an early signal of Alzheimer’s disease, but not always. Other health concerns could be causing thinking or memory problems, and the new drug, Aduhelm, would not be appropriate for those patients.
An Ad’s Charge That Price Haggling Would ‘Swipe $500 Billion From Medicare’ Is Incorrect
The ad, advanced by a right-leaning seniors advocacy organization, mischaracterizes proposals to bargain on drug prices, regarding both the effects on the Medicare program and on beneficiaries.
